FISH (fluorescent in situ hybridization): the second youth of cytogenetics.

he introduction of high resolution chromosome banding at the beginning of the eighties significantly improved the techniques for cancer cytogenetics. New criteria for classification and monitoring of leukemia and lymphoma have been established, and new insights into the understanding of the genetic bases of malignancies have been gained. l The limits of classical cytogenetics, however, are determined by the low number of metaphases available for analysis in some types of malignant hemopathies as well as by possible misinterpretations of banding in complex exchanges. Thus, much excitement was generated when the new techniques of molecular biology were introduced to investigate malignant hemo-pathies at the gene level. FlSH combines the resolution of molecular techniques with cytogenet-ics and allows the precise localization of nucleic acid sequences of interest on chromosomes or in interphase nuclei. 2 A single-stranded DNA probe hybridizes with a single-stranded sequence on a slide. Probes labeled with molecules such as biotin or digoxigenin may be detected after hybridization by using fluo-rochrome-conjugated molecules with green (fluorescein) and red (Texas red) coloration, respectively. DNA probes commonly available include centromeric Ͱ satellite probes, used in interphase analyses, 3 whole-chromosome specific probes, obtained from libraries of single chromosomes , which allow precise assignment of chromosome material (so-called chromosome painting), 4 locus-specific probes which detect restricted chromosome regions. 5 This last group of probes includes lambda phages, yeast artificial chromosome (YAC) and cosmids, which are vectors of DNA sequences of different sizes. In addition to DNA probes, RNA probes can localize transcription products. Furthermore morphology and immunophe-notyping may be combined with molecular cytogenetics in both metaphase and interphase. This technology may be applied on cryostat sections as well as on cytospin preparations, where metaphases are spread within an intact cytoplas-mic membrane. 6,7 Two recent papers in this journal show the usefulness of FISH in clinical hematology. Mancini et al. 8 studied a patient with a clinical picture suggestive of chronic myelogenous leukemia (CML), cytogenetically characterized by a t(9;21;22) with no clear involvement of chromosome 9. The dual color FISH technique performed by using specific painting probes for chromosomes 9, 21 and 22, and a bcr-abl translocation probe enabled them to confirm the diagnosis of CML by detecting bcr-abl rearrangement on chromosome 22q and involvement of chromosome 9 in a variant translocation t(9;21;22). The paper by Fugazza et al. 9 is an example of the association of interphase FISH with simultaneous evaluation of cell morphology. Results …

[1]  P. Fialkow,et al.  Evidence for a multistep pathogenesis of a myelodysplastic syndrome. , 1984, Blood.

[2]  D Pinkel,et al.  Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization , 1990, Science.

[3]  S. Thibodeau,et al.  Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. , 1990, Blood.

[4]  Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. , 1990 .

[5]  P. Taillon-Miller,et al.  Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: identification of 11q23 translocation breakpoints with a yeast artificial chromosome. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D C Ward,et al.  Analysis of genes and chromosomes by nonisotopic in situ hybridization. , 1991, Genetic analysis, techniques and applications.

[7]  B. Trask,et al.  DNA sequence mapping by fluorescence in situ hybridization , 1991, Environmental and molecular mutagenesis.

[8]  T. Cremer,et al.  Chromosomal in situ suppression hybridization of immunologically classified mitotic cells in hematologic malignancies , 1992, Genes, chromosomes & cancer.

[9]  J. Rowley,et al.  Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method. , 1992, Blood.

[10]  S. Jhanwar,et al.  Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization. , 1992, Blood.

[11]  A. Cuneo,et al.  Non‐radioactive in situ hybridization for the detection and monitoring of trisomy 12 in B‐cell chronic lymphocytic leukaemia , 1992, British journal of haematology.

[12]  D. Ledbetter The 'colorizing' of cytogenetics: is it ready for prime time? , 1992, Human molecular genetics.

[13]  D. Hossfeld,et al.  Identification of some marker chromosomes in acute leukemias by fluorescence in situ hybridization , 1993, Hematological oncology.

[14]  H. Döhner,et al.  High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics. , 1993, Blood.

[15]  R. Larson,et al.  Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion. , 1993, Blood.

[16]  P. Kluin,et al.  Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridization. , 1993, Blood.

[17]  S. Knuutila,et al.  Power of the MAC (Morphology‐Antibody‐Chromosomes) method in distinguishing reactive and clonal cells: Report of a patient with acute lymphatic leukemia, eosinophilia, and t(5;14) , 1993, Genes, chromosomes & cancer.

[18]  H. Döhner,et al.  High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics , 1993 .

[19]  B. Schlegelberger,et al.  Combined immunophenotyping and interphase cytogenetics on cryostat sections by the new FICTION method. , 1993, Leukemia.

[20]  D. Catovsky,et al.  Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology. , 1993, Blood.

[21]  R. Berger,et al.  t( 12;21): A new recurrent translocation in acute lymphoblastic leukemia , 1994, Genes, chromosomes & cancer.

[22]  C. Preudhomme,et al.  Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes. , 1994, Leukemia.

[23]  D. Catovsky,et al.  Trisomy 12 in B‐cell chronic lymphocytic leukaemia: assessment of lineage restriction by simultaneous analysis of immunophenotype and genotype in interphase cells by fluorescence in situ hybridization , 1994, British journal of haematology.

[24]  B. Barlogie,et al.  Deletion of the retinoblastoma gene in multiple myeloma. , 1994, Leukemia.

[25]  A. Chase,et al.  T lymphocytes in chronic myelogenous leukaemia (CML): no evidence of the BCR/ABL fusion gene detected by fluorescence in situ hybridization in 14 patients. , 1994, Leukemia.

[26]  C. Mecucci,et al.  Trisomy 12 is uncommon in typical chronic lymphocytic leukaemias , 1994, British journal of haematology.

[27]  R. Berger,et al.  Detection of monosomy 7 and trisomies 8 and 11 in myelodysplastic disorders by interphase fluorescent in situ hybridization. Comparison with acute non-lymphocytic leukemias. , 1994, Leukemia.

[28]  K. Franssila,et al.  Cell lineage involvement of recurrent chromosomal abnormalities in hematologic neoplasms , 1994, Genes, chromosomes & cancer.

[29]  M. Mancini,et al.  Application of fluorescence in situ hybridization in defining a complex t(9;21;22) Ph formation. , 1994, Haematologica.

[30]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[31]  Clonality study by fluorescence in situ hybridization of a patient with refractory anemia with ringed sideroblasts and monosomy 7. , 1995, Haematologica.